Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://journals.lww.com/ajsp/abstract/2012/02000/somatostatin_receptor_subtype_2a.10.aspx, but it redirected us to https://journals.lww.com/ajsp/abstract/2012/02000/somatostatin_receptor_subtype_2a.10.aspx. The analysis below is for the second page.

Title[redir]:
The American Journal of Surgical Pathology
Description:
re specific indications for use of immunohistochemistry for the somatostatin receptor subtype 2A, but this has up to now been limited by the lack of an adequate reliable antibody. The aim of this study was to correlate immunohistochemistry using the new monoclonal anti-somatostatin receptor subtype 2A antibody UMB-1 with the gold standard in vitro method quantifying somatostatin receptor levels in tumor tissues. A UMB-1 immunohistochemistry protocol was developed, and tumoral UMB-1 staining levels were compared with somatostatin receptor binding site levels quantified with in vitro 125I-[Tyr3]-octreotide autoradiography in 89 tumors. This allowed defining an immunohistochemical staining threshold permitting to distinguish tumors with somatostatin receptor levels high enough for clinical applications from those with low receptor expression. The presence of >10% positive tumor cells correctly predicted high receptor levels in 95% of cases. In contrast, absence of UMB-1 staining truly reflected low or undetectable somatostatin receptor expression in 96% of tumors. If 1% to 10% of tumor cells were stained, a weak staining intensity was suggestive of low somatostatin receptor levels. This study allows for the first time a reliable recommendation for eligibility of an individual patient for in vivo somatostatin receptor targeting based on somatostatin receptor immunohistochemistry. Under optimal methodological conditions, UMB-1 immunohistochemistry may be equivalent to in vitro receptor autoradiography....

Matching Content Categories {📚}

  • Education
  • Fitness & Wellness
  • Telecommunications

Content Management System {📝}

What CMS is doi.org built with?


Doi.org utilizes MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

receptor, somatostatin, journal, immunohistochemistry, levels, tumors, umb, issue, tumor, staining, access, subscribe, alerts, articles, authors, abstract, subtype, antibody, vivo, targeting, high, expression, vitro, low, log, register, logo, issues, monoclonal, suitable, buy, reliable, study, autoradiography, cells, individual, text, subscribers, request, browse, content, submit, service, privacy, policy, secondary, advanced, search, info, previous,

Topics {✒️}

vitro 125i-[tyr3]-octreotide autoradiography vitro receptor autoradiography somatostatin receptor expression somatostatin receptor immunohistochemistry low receptor expression adequate reliable antibody radiolabeled somatostatin analogues journal authors submit full text access umb-1 immunohistochemistry protocol weak staining intensity optimal methodological conditions artificial intelligence training tumor cells etoc alerts service request 800-638-3030 umb-1 staining register subscribe umb-1 immunohistochemistry somatostatin receptors american journal journal tables individual subscribers log issue tumor tissues correlate immunohistochemistry meike md aurel md reflected low website subscribe journal reliable recommendation individual patient center submit neuroendocrine tumors distinguish tumors agnes phd† surgical pathology 36 specific indications gold standard allowed defining clinical applications email inbox rights reserved data mining tumor immunohistochemistry suitable authors content

Questions {❓}

  • Not a Subscriber?

Social Networks {👍}(1)

External Links {🔗}(58)

Analytics and Tracking {📊}

  • Comscore
  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Scite
  • Wolterskluwer

4.76s.